Most telehealth platforms that offer weight loss programs are familiar with these requests and can provide the necessary documentation after your consultation
As both a GLP-1 and GIP agonist, Tirzepatide enhances weight loss effects beyond GLP-1-only therapy
Semaglutide binds to GLP-1 receptors in the brain, particularly in the hypothalamus, reducing hunger signals and increasing satiety
Instead of moving food into the small intestine, the stomach becomes slow, dysfunctional, or completely paralyzed causing chronic nausea, vomiting, abdominal pain, severe bloating, and long-term digestive impairment
Studies show that abruptly discontinuing GLP-1 therapy almost always results in rapid weight regainoften within weeks to monthsbecause your body's appetite-suppressing pathways slowly return to baseline
Tirzepatide effects on gut function could, through vagal signaling, influence the brain anxiety thermostat in ways that vary dramatically between individuals